Literature DB >> 28120134

Optimizing Follow-up Assessment of Patients with Cutaneous Melanoma.

Neal Bhutiani1, Michael E Egger2, Kelly M McMasters3.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28120134     DOI: 10.1245/s10434-017-5771-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  A Retrospective Analysis of Surveillance Adherence of Patients after Treatment of Primary Cutaneous Melanoma.

Authors:  Jeave Reserva; Monica Janeczek; Cara Joyce; Amanda Goslawski; Hwala Hong; Feng-Ning Yuan; Neelam Balasubramanian; Laura Winterfield; James Swan; Rebecca Tung
Journal:  J Clin Aesthet Dermatol       Date:  2017-12-01

2.  Tumour gene expression signature in primary melanoma predicts long-term outcomes.

Authors:  David J Adams; Alvis Brazma; Roy Rabbie; Manik Garg; Dominique-Laurent Couturier; Jérémie Nsengimana; Nuno A Fonseca; Matthew Wongchenko; Yibing Yan; Martin Lauss; Göran B Jönsson; Julia Newton-Bishop; Christine Parkinson; Mark R Middleton; D Timothy Bishop; Sarah McDonald; Nikki Stefanos; John Tadross; Ismael A Vergara; Serigne Lo; Felicity Newell; James S Wilmott; John F Thompson; Georgina V Long; Richard A Scolyer; Pippa Corrie
Journal:  Nat Commun       Date:  2021-02-18       Impact factor: 17.694

3.  Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.

Authors:  Eddy C Hsueh; James R DeBloom; Jonathan Lee; Jeffrey J Sussman; Kyle R Covington; Brooke Middlebrook; Clare Johnson; Robert W Cook; Craig L Slingluff; Kelly M McMasters
Journal:  J Hematol Oncol       Date:  2017-08-29       Impact factor: 17.388

4.  Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol.

Authors:  Mbathio Dieng; Nikita Khanna; Mai Thi Hoang Nguyen; Robin Turner; Sarah J Lord; Alexander M Menzies; Jay Allen; Robyn Saw; Omgo E Nieweg; John Thompson; Rachael L Morton
Journal:  BMJ Open       Date:  2020-11-05       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.